KemPharm Hits Shire With Antitrust Counterclaims
KemPharm filed the counterclaims in the U.S. District Court for the Western District of Virginia in response to a complaint Shire filed in September.
Shire is the maker of attention deficit hyperactivity disorder drug Adderall. In 2007 it acquired New River Pharmaceuticals Inc., the maker of...
To view the full article, register now.